Home › Non-Small Cell Lung Cancer › Illinois › Waukegan
Non-Small Cell Lung Cancer clinical trials in Waukegan, IL
16 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Waukegan (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi away
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- City of Hope Chicago, Zion · 6 mi away
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RecruitingPhase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi away
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RecruitingPhase 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi away
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi away
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RecruitingPhase 3
- Research Site, Zion · 6 mi away
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RecruitingPhase 3
- Research Site, North Chicago · 3 mi away
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RecruitingPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi away
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
- and 1 more
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
- and 1 more
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
- and 1 more
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi away
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RecruitingPhase 2
- City of Hope at Chicago, Zion · 6 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Waukegan
- Lung Cancer16 studies
- Breast Cancer12 studies
- Ulcerative Colitis7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Ovarian Cancer6 studies
- Metastatic Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Melanoma5 studies
- Acute Myeloid Leukemia5 studies
- Crohn's Disease5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.